GENSCRIPT BIO(01548): Legend to present latest data at the American Society of Hematology annual meeting.

GENSCRIPT BIO (01548) announced that Legend Biotech Corporation (a company affiliated with the company, whose shares are listed on the Nasdaq Global Select Market in the form of American Depositary Shares) submitted a Form 6-K to the U.S. Securities and Exchange Commission on November 3, 2025 (New York time) (prior to the Hong Kong trading hours on November 4, 2025), and announced that it will present the latest data related to CARVYKTI and other pipelines at the 67th Annual Meeting of the American Society of Hematology, to be held in San Diego from December 6 to 9, 2025.